PD Dr. med. habil. Julia Anna Bielicki

Kakaraskoska Boceska, Biljana, Vilken, Tuba, Xavier, Basil Britto, Kostyanev, Tomislav, Lin, Qiang, Lammens, Christine, Ellis, Sally, O’Brien, Seamus, da Costa, Renata Maria Augusto, Cook, Aislinn, Russell, Neal, Bielicki, Julia, Riddell, Amy, Stohr, Wolfgang, Walker, Ann Sarah, Berezin, Eitan Naaman, Roilides, Emmanuel, De Luca, Maia, Romani, Lorenza, et al. (2024). Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-48296-z

Rodriguez-Ruiz, J. P., Xavier, B. B., Stöhr, W., van Heirstraeten, L., Lammens, C., Finn, A., Goossens, H., Bielicki, J. A., Sharland, M., & Malhotra-Kumar, S. (2024). High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03300-w

Dangor, Ziyaad, Benson, Nicole, Berkley, James A., Bielicki, Julia, Bijsma, Merijn W., Broad, Jonathan, Buurman, Ed T., Cross, Alan, Duffy, Erin M., Holt, Kathryn E., Iroh Tam, Pui-Ying, Jit, Mark, Karampatsas, Konstantinos, Katwere, Michael, Kwatra, Gaurav, Laxminarayan, Ramanan, Le Doare, Kirsty, Mboizi, Robert, Micoli, Francesca, et al. (2024). Vaccine value profile for Klebsiella pneumoniae. Vaccine, 42(19), S125–S141. https://doi.org/10.1016/j.vaccine.2024.02.072

Aghlmandi, Soheila, Bielicki, Julia, & Bucher, Heiner C. (2024). ‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ – Author’s reply. Clinical Microbiology and Infection, 30(7), 967–968. https://doi.org/10.1016/j.cmi.2024.03.030

Anliker-Ort, Marion, Rodieux, Frédérique, Ziesenitz, Victoria C., Atkinson, Andrew, Bielicki, Julia A., Erb, Thomas O., Gürtler, Nicolas, Holland-Cunz, Stefan, Duthaler, Urs, Rudin, Deborah, Haschke, Manuel, van den Anker, John, Pfister, Marc, & Gotta, Verena. (2024). Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study. Journal of Clinical Pharmacology, 64(7), 810–819. https://doi.org/10.1002/jcph.2428

Abel, K., Agnew, E., Amos, J., Armstrong, N., Armstrong-James, D., Ashfield, T., Aston, S., Baillie, J. K., Baldwin, S., Barlow, G., Bartle, V., Bielicki, J., Brown, C., Carrol, E., Clements, M., Cooke, G., Dane, A., Dark, P., Day, J., et al. (2024). System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework. The Lancet Microbe, 5(5), e500–e507. https://doi.org/10.1016/S2666-5247(24)00003-X

Minotti, C., Aghlmandi, S., & Bielicki, J.A. (2024). Electronic hand hygiene monitoring tools for implementation of optimal hand sanitizing adherence in neonatal intensive care. Journal of Hospital Infection, 147, 213–215. https://doi.org/10.1016/j.jhin.2024.02.018

Schlaeppi, Chloé, Minotti, Chiara, & Bielicki, Julia Anna. (2024). Infection Control in the NICU: The Roles of Surveillance Cultures. Pediatric Infectious Disease Journal, 43(5), E175–E177. https://doi.org/10.1097/INF.0000000000004293

Operations, Clinical, Yau, Yasmine, Vitale, Elia, Vecchia, Giulio, D’Ambrosio, Federica, Bouwman, Wietske, van Esschoten, Marjolein, Leus, Frank, de Pooter, David, Timbermont, Leen, Ruiz, Juan Pablo Rodriguez, Hommel, Benjamin, Tessonneau, Marie, Vasconcelos, Malte Kohns, Malhotra-Kumar, Surbhi, Allantaz, Florence, Vandepitte, Sophie, Tissier, Jean-Louis, Cleuziat, Philippe, et al. (2024). Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial. BMJ Open, 14(4). https://doi.org/10.1136/bmjopen-2023-076338

Blanchard-Rohner, Geraldine, Sanchez, Carlos, Andre, Maya C., Bressieux-Degueldre, Sabrina, Grazioli, Serge, Perez, Marie-Helene, Wütz, Daniela, Schöbi, Nina, Welzel, Tatjana, Atkinson, Andrew, Schlapbach, Luregn J., Bielicki, Julia A., Trück, Johannes, Koehler, Henrik, Gysi, Spyridoula, Janz, Indra, Bieri, Andreas, Donner, Birgit, Hammer, Jürg, et al. (2024). COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children. Pediatric Infectious Disease Journal, 43(4), 361–364. https://doi.org/10.1097/INF.0000000000004206

Gotta, Verena, Bielicki, Julia Anna, Paioni, Paolo, Csajka, Chantal, Bräm, Dominic Stefan, Berger, Christoph, Giger, Elisabeth, Buettcher, Michael, Posfay-Barbe, Klara M., Van Den Anker, John, & Pfister, Marc. (2024). Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin. Swiss Medical Weekly, 154(4). https://doi.org/10.57187/s.3632

Russell, Neal, Clements, Michelle N., Azmery, Kazi Shammin, Bekker, Adrie, Bielicki, Julia, Dramowski, Angela, Ellis, Sally, Fataar, Aaqilah, Hoque, Mahbubul, LeBeau, Kristen, O’Brien, Seamus, Schiavone, Francesca, Skoutari, Peter, Islam, Mohammad Shahidul, Saha, Samir K., Walker, Ann Sarah, Whitelaw, Andrew, & Sharland, Michael. (2024). Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial [Journal-article]. eClinicalMedicine, 69, 102463. https://doi.org/10.1016/j.eclinm.2024.102463

Sartorius, B., Gray, A. P., Davis Weaver, N., Robles Aguilar, G., Swetschinski, L. R., Ikuta, K. S., Mestrovic, T., Chung, E., Wool, E. E., Han, C., Gershberg Hayoon, A., Araki, D. T., Abd-Elsalam, S., Aboagye, R. G., Adamu, L. H., Adepoju, A. V., Ahmed, A., Akalu, G. T., Akande-Sholabi, W., et al. (2024). The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. The Lancet Global Health, 12(2), e201–e216. https://doi.org/10.1016/S2214-109X(23)00539-9

Aghlmandi, Soheila, Halbeisen, Florian S., Godet, Pascal, Signorell, Andri, Sigrist, Simon, Saccilotto, Ramon, Widmer, Andreas F., Zeller, Andreas, Bielicki, Julia, & Bucher, Heiner C. (2024). Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland. Clinical Microbiology and Infection, 30, 353–359. https://doi.org/10.1016/j.cmi.2023.11.010

Andre, Maya C., Carlos, Sanchez, Sabrina, Bressieux-Degueldre, Marie-Helene, Perez, Daniela, Wütz, Geraldine, Blanchard-Rohner, Serge, Grazioli, Nina, Schöbi, Johannes, Trück, Tatjana, Welzel, Andrew, Atkinson, Schlapbach, Luregn J., Julia, Bielicki, Sanchez, Carlos, Bressieux-Degueldre, Sabrina, Perez, Marie-Helene, Wütz, Daniela, Blanchard-Rohner, Geraldine, Grazioli, Serge, et al. (2024). Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial. eClinicalMedicine, 67. https://doi.org/10.1016/j.eclinm.2023.102358

Bender, Rose Grace, Sirota, Sarah Brooke, Swetschinski, Lucien R., Dominguez, Regina-Mae Villanueva, Novotney, Amanda, Wool, Eve E., Ikuta, Kevin S., Vongpradith, Avina, Rogowski, Emma Lynn Best, Doxey, Matthew, Troeger, Christopher E., Albertson, Samuel B., Ma, Jianing, He, Jiawei, Maass, Kelsey Lynn, Simões, Eric A. F., Abdoun, Meriem, Aziz, Jeza Muhamad Abdul, Abdulah, Deldar Morad, et al. (2024). Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases, 24, 974–1002. https://doi.org/10.1016/S1473-3099(24)00176-2

Benvenga, Vanni, Cuénod, Aline, Purushothaman, Srinithi, Dasen, Gottfried, Weisser, Maja, Bassetti, Stefano, Roloff, Tim, Siegemund, Martin, Heininger, Ulrich, Bielicki, Julia, Wehrli, Marianne, Friderich, Paul, Frei, Reno, Widmer, Andreas, Herzog, Kathrin, Fankhauser, Hans, Nolte, Oliver, Bodmer, Thomas, Risch, Martin, et al. (2024). Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collection. Genome Medicine, 16. https://doi.org/10.1186/s13073-024-01292-w

Bertagnolio, Silvia, Dobreva, Zlatina, Centner, Chad M, Olaru, Ioana Diana, Donà, Daniele, Burzo, Stefano, Huttner, Benedikt D, Chaillon, Antoine, Gebreselassie, Nebiat, Wi, Teodora, Hasso-Agopsowicz, Mateusz, Allegranzi, Benedetta, Sati, Hatim, Ivanovska, Verica, Kothari, Kavita U, Balkhy, Hanan H, Cassini, Alessandro, Hamers, Raph L, Weezenbeek, Kitty Van, et al. (2024). WHO global research priorities for antimicrobial resistance in human health. The Lancet Microbe, 5. https://doi.org/10.1016/S2666-5247(24)00134-4

Bielicki, Julia Anna. (2024). Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization. Clinical Microbiology and Infection, 30(1), 20–21. https://doi.org/10.1016/j.cmi.2023.10.025

Meyer Sauteur, Patrick M., Seiler, Michelle, Tilen, Romy, Osuna, Ester, von Wantoch, Margarete, Sidorov, Semjon, Aebi, Christoph, Agyeman, Philipp, Barbey, Florence, Bielicki, Julia A., Coulon, Ludivine, Deubzer, Beate, Donas, Alex, Heininger, Ulrich, Keitel, Kristina, Köhler, Henrik, Kottanattu, Lisa, Lauener, Roger, Niederer-Loher, Anita, et al. (2024). A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study. Trials, 25. https://doi.org/10.1186/s13063-024-08438-6

Sayood, Sena, Bielicki, Julia, & Gandra, Sumanth. (2024). Tackling inappropriate antibiotic use in low-and middle-income countries. Nature Medicine, 30(1), 33–34. https://doi.org/10.1038/s41591-023-02725-6

Schöbi, Nina, Sanchez, Carlos, Welzel, Tatjana, Bamford, Alasdair, Webb, Kate, Rojo, Pablo, Tremoulet, Adriana, Atkinson, Andrew, Schlapbach, Luregn J., Bielicki, Julia Anna, Andre, Maya C., Bailey, Douggl G.N., Blanchard-Rohner, Geraldine, Buettcher, Michael, Grazioli, Serge, Koehler, Henrik, Perez, Maria-Helena, Trück, Johannes, Vanoni, Federica, & Zimmermann, Petra. (2024). Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARSCoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland [Journal-article]. BMJ Open, 14(4), e078137. https://doi.org/10.1136/bmjopen-2023-078137

Turner, Rebecca M., Lee, Kim May, Walker, A. Sarah, Ellis, Sally, Sharland, Michael, Bielicki, Julia A., Stöhr, Wolfgang, & White, Ian R. (2024). Determining sample size in a personalized randomized controlled (PRACTical) trial. Statistics in Medicine, 43, 4098–4112. https://doi.org/10.1002/sim.10168

Bielicki, I., Schmid, H., Atkinson, A., Kahlert, C. R., Berger, C., Troillet, N., Marschall, J., & Bielicki, J. A. (2023). Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study [Journal-article]. Antimicrobial Resistance and Infection Control, 12(1). https://doi.org/10.1186/s13756-023-01312-1

Boceska, B. K., Vilken, T., Xavier, B. B., Lammens, C., Ellis, S., O’Brien, S., da Costa, R. M. A., Cook, A., Russell, N., Bielicki, J., Berezin, E. N., Roilides, E., Luca, M. D., Romani, L., Ballot, D., Dramowski, A., Wadula, J., Lochindarat, S., Boonkasidecha, S., et al. (2023). Identification of potential novel combination antibiotic regimens based on drug-susceptibility and genetic diversity of Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.10.20.23296805

Gruppenautorenschaft. (2023). Antibiotics and uncertainty of diagnosis in viral respiratory infections: Point-prevalence survey across 15 European countries [Journal-article]. Acta Paediatrica, International Journal of Paediatrics, 112(9), 1970–1972. https://doi.org/10.1111/apa.16855

Dharmapalan, D., Bielicki, J., & Sharland, M. (2023). Harmonization of Amoxicillin Dose, Duration, and Formulation for Acute Childhood Respiratory Infections. Antibiotics, 12(7). https://doi.org/10.3390/antibiotics12071138

McMullan, Brendan, Bryant, Penelope A, Duffy, Eamon, Bielicki, Julia, De Cock, Pieter, Science, Michelle, Zembles, Tracy, Timberlake, Kathryn, Monsees, Elizabeth, Hamdy, Rana F, Tribble, Alison C, Newland, Jason, & Patel, Sanjay. (2023). Multinational consensus antimicrobial stewardship recommendations for children managed in hospital settings. The Lancet Infectious Diseases, 23(6), e199–e207. https://doi.org/10.1016/S1473-3099(22)00726-5

Russell, N. J., Stohr, W., Plakka, N., Cook, A., Berkley, J. A., Adhisivam, B., Agarwal, R., Ahmed, N. U., Balasegaram, M., Ballot, D., Bekker, A., Berezin, E. N., Bilardi, D., Boonkasecha, S., Carvalheiro, C. G., Chami, N., Chaurasia, S., Chiurchiu, S., Colas, V. R. F., et al. (2023). Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS). PLoS Medicine, 20(6 June). https://doi.org/10.1371/journal.pmed.1004179

Cook, A., Atkinson, A., Kronenberg, A., Agyeman, P. K. A., Schlapbach, L. J., Berger, C., & Bielicki, J. A. (2023). Estimating antibiotic coverage from linked microbiological and clinical data from the Swiss Paediatric Sepsis Study to support empiric antibiotic regimen selection [Journal-article]. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1124165

Malhotra-Kumar, S., Rodriguez, J.-P., Xavier, B., Stohr, W., Heirstraeten, L. V., Lammens, C., Finn, A., Goossens, H., Bielicki, J., & Sharland, M. (2023). High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-2851795/v1

Riddell, Amy, Cook, Aislinn, Khavessian, Nathalie, Ellis, Sally, Bilardi, Davide, Correia, Erika, Kostyanev, Tomislav, Nardone, Alessandra, Russell, Neal, Vilken, Tuba, Stohr, Wolfgang, Adhisivam, Bethou, Moraes, Iana Rosa Alves de, Ahmed, Nawshad Uddin, Bekker, Adrie, Berezin, Eitan Naaman, Boonkasidecha, Suppawat, Carvalheiro, Cristina G., Chauhan, Prachi, et al. (2023). Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting [Journal-article]. Antibiotics, 12(5), 923. https://doi.org/10.3390/antibiotics12050923

Benvenga, V., Cuénod, A., Purushothaman, i., Dasen, G., Weisser, M., Bassetti, S., Roloff, T., Siegemund, M., Heininger, U., Bielicki, J., Wehrli, M., Friderich, P., Frei, R., Widmer, A., Herzog, K., Fankhauser, H., Nolte, O., Bodmer, T., Risch, M., et al. (2023, April 27). Ancient methicillin-resistant<i>Staphylococcus aureus</i>: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collection [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.04.27.538514

Cook, Aislinn, Ferreras-Antolin, Laura, Adhisivam, Bethou, Ballot, Daynia, Berkley, James A, Bernaschi, Paola, Carvalheiro, Cristina G, Chaikittisuk, Napaporn, Chen, Yunsheng, Chibabhai, Vindana, Chitkara, Shweta, Chiurchiu, Sara, Chorafa, Elisavet, Dien, Tran Minh, Dramowski, Angela, de Matos, Samantha Faria, Feng, Jinxing, Jarovsky, Daniel, Kaur, Ravinder, et al. (2023). Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study [Journal-article]. Medical Mycology, 61(3). https://doi.org/10.1093/mmy/myad010

Colosi, Elisabetta, Bassignana, Giulia, Barrat, Alain, Lina, Bruno, Vanhems, Philippe, Bielicki, Julia, & Colizza, Vittoria. (2023). Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022. Eurosurveillance, 28(5). https://doi.org/10.2807/1560-7917.ES.2023.28.5.2200192

Aghlmandi, Soheila, Halbeisen, Florian S., Saccilotto, Ramon, Godet, Pascal, Signorell, Andri, Sigrist, Simon, Glinz, Dominik, Moffa, Giusi, Zeller, Andreas, Widmer, Andreas F., Kronenberg, Andreas, Bielicki, Julia, & Bucher, Heiner C. (2023). Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care: A Randomized Clinical Trial. JAMA Internal Medicine, 183, 213–220. https://doi.org/10.1001/jamainternmed.2022.6529

Kohns Vasconcelos, M., Meyer Sauteur, P. M., Keitel, K., Santoro, R., Egli, A., Coslovsky, M., Seiler, M., Lura, M., Köhler, H., Loevy, N., Kahlert, C. R., Heininger, U., Van den Anker, J., & Bielicki, J. A. (2023). Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland - baseline findings from the first two years of the KIDS-STEP trial. Swiss Med Wkly, 153, 40040. https://doi.org/10.57187/smw.2023.40040

Welzel, Tatjana, Atkinson, Andrew, Schöbi, Nina, Andre, Maya C, Bailey, Douggl G N, Blanchard-Rohner, Geraldine, Buettcher, Michael, Grazioli, Serge, Koehler, Henrik, Perez, Marie-Helene, Trück, Johannes, Vanoni, Federica, Zimmermann, Petra, Sanchez, Carlos, Bielicki, Julia A, Schlapbach, Luregn J, Bieri, Andreas, Gysi, Spyridoula, Janz, Indra, et al. (2023). Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial. The Lancet Child and Adolescent Health, 7, 238–248. https://doi.org/10.1016/S2352-4642(23)00020-2

Zay Ya, K., Win, P. T. N., Bielicki, J., Lambiris, M., & Fink, G. (2023). Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis. JAMA Netw Open, 6(2), e2253806. https://doi.org/10.1001/jamanetworkopen.2022.53806

Bielicki I, Subotic U, & Bielicki JA. (2022). Systematic literature review on surgical site preparation in paediatric surgery. BMC Pediatrics, 22(1), 455. https://doi.org/10.1186/s12887-022-03502-z

Hassoun-Kheir N, van Werkhoven CH, Dunning J, Jaenisch T, van Beek J, Bielicki J, Butler CC, Francois B, Harbarth S, Hernandez Padilla AC, Horby P, Koopmans M, Lee J, Rodriguez-Baño J, Tacconelli E, Themistocleous Y, van der Velden AW, Bonten M, Goossens H, et al. (2022). Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases. Clinical Microbiology and Infection, 28(12), 1528–1532. https://doi.org/10.1016/j.cmi.2022.07.024

Villabruna N, Izquierdo-Lara RW, Schapendonk CME, de Bruin E, Chandler F, Thao TTN, Westerhuis BM, van Beek J, Sigfrid L, Giaquinto C, Goossens H, Bielicki JA, Kohns Vasconcelos M, Fraaij PLA, Koopmans MPG, & de Graaf M. (2022). Profiling of humoral immune responses to norovirus in children across Europe. Scientific Reports, 12(1), 14275. https://doi.org/10.1038/s41598-022-18383-6

Williams, P. C. M., Qazi, S. A., Agarwal, R., Velaphi, S., Bielicki, J. A., Nambiar, S., Giaquinto, C., Bradley, J., Noel, G. J., Ellis, S., O’brien, S., Balasegaram, M., & Sharland, M. (2022). Antibiotics needed to treat multidrug-resistant infections in neonates Antibiotiques nécessaires au traitement des infections multirésistantes chez les nouveaunés Se necesitan antibióticos para tratar las infecciones multirresistentes en los recién nacidos. Bulletin of the World Health Organization, 100(12), 797–807. https://doi.org/10.2471/BLT.22.288623

Nyantakyi E, Caci L, Castro M, Schlaeppi C, Cook A, Albers B, Walder J, Metsvaht T, Bielicki J, Dramowski A, Schultes MT, & Clack L. (2022). Implementation of infection prevention and control for hospitalized neonates: A narrative review. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2022.11.007

Bielicki J.A., & Manuel O. (2022). Antimicrobial stewardship programs in solid-organ transplant recipients in Switzerland. Transplant Infectious Disease, 24(5). https://doi.org/10.1111/tid.13902

Kopsidas I, De Luca M, Bielicki J, Blázquez-Gamero D, von Both U, Ciliento G, Epalza C, Goycochea Validivia WA, Kolberg L, Lutsar I, Machaira M, Neth O, Oletto A, Tsolia MN, Viltrop AL, Zaoutis T, & Spyridis N. (2022). Hand Hygiene Compliance Rates in 9 Pediatric Intensive Care Units Across Europe: Results from the Reducing Antimicrobial use and Nosocomial Infections in Kids Network. Pediatric Infectious Disease Journal, 41(10), E434–E437. https://doi.org/10.1097/INF.0000000000003658

Sharland E, Qazi S, Heath P, Balasegaram M, Bielicki J, & Sharland M. (2022). Can the history of empiric antibiotic treatment for neonatal sepsis inform future global trials? Clinical Microbiology and Infection, 28(10), 1313–1315. https://doi.org/10.1016/j.cmi.2022.06.006

Paioni, Paolo, Aebi, Christoph, Bielicki, Julia, Buettcher, Michael, Crisinel, Pierre Alex, Kahlert, Christian R., Wagner, Noémie, Berger, Christoph, Agyeman P., Asner S., Azzi T., Bar W., Barbey F., Bernhard-Stirnemann S., Bonhoeffer J., Desgrandchamps D., Diana A., Deak C., Dierig A., et al. (2022). Swiss recommendations on perioperative antimicrobial prophylaxis in children. Swiss Medical Weekly, 152(3738). https://doi.org/10.4414/SMW.2022.w30230

Mack I., Juchler N., Rey S., Hirsch S., Hoelz B., Eckstein J., & Bielicki J. (2022). Wearable Technologies for Pediatric Patients with Surgical Infections—More than Counting Steps? Biosensors, 12(8). https://doi.org/10.3390/bios12080634

Russell, N., Stöhr, W., Cook, A., Berkley, J. A., Adhisivam, B., Agarwal, R., Ahmed, N. U., Balasegaram, M., Chami, N., Bekker, A., Bilardi, D., Carvalheiro, C. G., Chaurasia, S., Favarin Colas, V. R., Cousens, S., Dantas de Assis, A. C., Dong, H., Dramowski, A., Dung, N. T., et al. (2022). The NeoSep Severity and Recovery scores to predict mortality in hospitalized neonates and young infants with sepsis derived from the global NeoOBS observational cohort study [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.06.21.22276677

Russell, N., Stöhr, W., Plakkal, N., Cook, A., Berkley, J. A., Adhisivam, B., Agarwal, R., Balasegaram, M., Ballot, D., Bekker, A., Berezin, E. N., Bilardi, D., Boonkasidecha, S., Carvalheiro, C. G., Chaurasia, S., Chiurchiu, S., Cousens, S., Cressey, T. R., Dien, T. M., et al. (2022). Patterns of antibiotic use, pathogens and clinical outcomes in hospitalised neonates and young infants with sepsis in the NeoOBS global neonatal sepsis observational cohort study [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.06.20.22276674

Tilen R, Paioni P, Goetschi AN, Goers R, Seibert I, Müller D, Bielicki JA, Berger C, Krämer SD, & Meyer Zu Schwabedissen HE. (2022). Pharmacogenetic Analysis of Voriconazole Treatment in Children. Pharmaceutics, 14(6). https://doi.org/10.3390/pharmaceutics14061289

Verberk JDM, de Hoog MLA, Westerhof I, van Goethem S, Lammens C, Ieven G, de Bruin E, Eggink D, Bielicki JA, Coenen S, van Beek J, Bonten MJM, Goossens H, & Bruijning-Verhagen PCJL. (2022). Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries. European Journal of Epidemiology, 37(5), 549–561. https://doi.org/10.1007/s10654-022-00870-9

Bielicki JA, & Sharland M. (2022). Amoxicillin Dose and Duration of Treatment and Need for Antibiotic Re-treatment in Children with Community-Acquired Pneumonia - Reply (Patent No. 11). 327(11), Article 11. https://doi.org/10.1001/jama.2022.1046

Murray, C. J., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0

Colosi, E., Bassignana, G., Barrat, A., Lina, B., Vanhems, P., Bielicki, J., & Colizza, V. (2022). Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.02.04.22270473

Bruningk, Sarah C., Klatt, Juliane, Stange, Madlen, Mari, Alfredo, Brunner, Myrta, Roloff, Tim-Christoph, Seth-Smith, Helena M. B., Schweitzer, Michael, Leuzinger, Karoline, Sogaard, Kirstine K., Torres, Diana Albertos, Gensch, Alexander, Schlotterbeck, Ann-Kathrin, Nickel, Christian H., Ritz, Nicole, Heininger, Ulrich, Bielicki, Julia, Rentsch, Katharina, Fuchs, Simon, et al. (2022). Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area. Virus Evolution, 8(1), veac002. https://doi.org/10.1093/ve/veac002

Cook A, Sharland M, Yau Y, Group P, Bielicki J, & PediBSI Group. (2022). Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA). Expert Review of Anti-Infective Therapy, 20(3), 445–456. https://doi.org/10.1080/14787210.2021.1967145

Huber, Francois, Lang, Hans Peter, Heller, Stefanie, Bielicki, Julia Anna, Gerber, Christoph, Meyer, Ernst, & Egli, Adrian. (2022). Rapid Bacteria Detection from Patients’ Blood Bypassing Classical Bacterial Culturing. Biosensors, 12(11), 994. https://doi.org/10.3390/bios12110994

Levine, G., Bielicki, J., & Fink, G. (2022). Cumulative antibiotic exposure in the first five years of life: estimates for 45 low- and middle-income countries from demographic and health survey data. Clinical Infectious Diseases, 75(9), 1537–1547. https://doi.org/10.1093/cid/ciac225

Saul, H., Gursul, D., Cassidy, S., & Bielicki, J. (2022). A short course of antibiotics is effective for treating pneumonia in children. The BMJ. https://doi.org/10.1136/bmj.o1767

Smit, C., Sen, S., von Dach, E., Karmime, A., Lescuyer, P., Tonoli, D., Bielicki, J., Huttner, A., & Pfister, M. (2022). Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure. Antibiotics (Basel), 11(9), 1190. https://doi.org/10.3390/antibiotics11091190

Welzel T, Schöbi N, André MC, Bailey DGN, Blanchard-Rohner G, Buettcher M, Grazioli S, Koehler H, Perez MH, Trück J, Vanoni F, Zimmermann P, Atkinson A, Sanchez C, Whittaker E, Faust SN, Bielicki JA, Schlapbach LJ, & Swissped Recovery Trial. (2022). Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial. Frontiers in Pediatrics, 10, 905046. https://doi.org/10.3389/fped.2022.905046

Bielicki I, Subotic U, & Bielicki JA. (2022). Systematic literature review on surgical site prevention in paediatric surgery. BMC Pediatrics.

Stange M, Wuerfel E, Peter JK, Seth-Smith H, Roloff T, Gsponer S, Mari A, Cabrera Gil B, Lebrand A, Wegner F, Heininger U, Bielicki J, Tschudin Sutter S, Stadler T, Leuzinger K, Hirsch HH, Ledergerber M, Fuchs S, & Egli A. (2022). SARS-CoV-2 in schools: genome analysis shows that concurrent cases in the second 2 and third wave were often unconnected. medRxiv Preprint. https://doi.org/10.1101/2022.01.26.22269824

Goers R, Coman Schmid D, Jäggi VF, Paioni P, Okoniewski MJ, Parker A, Bangerter B, Georgakopoulou S, Sengstag T, Bielicki J, Tilen R, Vermeul S, Krämer SD, Berger C, Rinn B, & Meyer Zu Schwabedissen HE. (2021). SwissPKcdw – A clinical data warehouse for the optimization of pediatric dosing regimens. CPT: Pharmacometrics and Systems Pharmacology, 10(12), 1578–1587. https://doi.org/10.1002/psp4.12723

O’Brien, K. S., Arzika, A., Amza, A., Maliki, R., Ousmane, S., Kadri, B., Nassirou, B., Mankara, A. K., Harouna, A. N., Colby, E., Lebas, E., Liu, Z., Le, V., Nguyen, W., Keenan, J. D., Oldenburg, C. E., Porco, T. C., Doan, T., Arnold, B., et al. (2021). Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR). BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-10824-7

Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, Sturgeon K, Finn A, Rodriguez-Ruiz JP, Malhotra-Kumar S, Powell C, Faust SN, Alcock AE, Hall D, Robinson G, Hawcutt DB, Lyttle MD, Gibb DM, Sharland M, & PERUKI, GAPRUKI, and the CAP-IT Trial Group. (2021). Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children with Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. JAMA - Journal of the American Medical Association, 326(17), 1713–1724. https://doi.org/10.1001/jama.2021.17843

Manz N, Höfele-Behrendt C, Bielicki J, Schmid H, Matter M.S., Bielicki I, Holland-Cunz S, & Gros S.J. (2021). Mis-c-implications for the pediatric surgeon: An algorithm for differential diagnostic considerations. Children, 8(8). https://doi.org/10.3390/children8080712

Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang’wa M, Keers S, et al. (2021). Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study. BMJ Open Respiratory Research, 8(1). https://doi.org/10.1136/bmjresp-2021-000887

Folgori L, Di Carlo D, Comandatore F, Piazza A, Witney AA, Bresesti I, Hsia Y, Laing K, Monahan I, Bielicki J, Alvaro A, Zuccotti GV, Planche T, Heath PT, & Sharland M. (2021). Antibiotic susceptibility, virulome, and clinical outcomes in european infants with bloodstream infections caused by enterobacterales. Antibiotics, 10(6). https://doi.org/10.3390/antibiotics10060706

Clements MN, Russell N, Bielicki JA, Ellis S, Gastine S, Hsia Y, Standing JF, Walker AS, & Sharland M. (2021). Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines. PLoS ONE, 16(5 May), e0252223. https://doi.org/10.1371/journal.pone.0252223

Schmid Hanna, Heininger Ulrich, Vuichard-Gysin Danielle, Widmer Andreas, & Bielicki Julia. (2021). Preventive measures for accompanying caregivers of children in paediatric health care during the COVID-19 pandemic—walking an ethical tightrope. Clinical Microbiology and Infection, 27(5), 668–670. https://doi.org/10.1016/j.cmi.2021.01.023

Tubiana S, Burdet C, Houhou N, Thy M, Manchon P, Blanquart F, Charpentier C, Guedj J, Alavoine L, Behillil S, Leclercq A, Lucet JC, Yazdanpanah Y, Attia M, Demeret C, Rose T, Bielicki JA, Bruijning-Verhagen P, Goossens H, et al. (2021). High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort (Patent No. 5). 82(5), Article 5. https://doi.org/10.1016/j.jinf.2021.01.026

Verberk, J., de Hoog, M., Westerhof, I., Van Goethem, S., Lammens, C., Ieven, M., de Bruin, E., Bielicki, J., Coenen, S., van Beek, J., Bonten, M., Goossens, H., & Bruijning-Verhagen, P. (2021). Transmission of SARS-CoV-2 within households: a prospective cohort study in the Netherlands and Belgium – Interim results [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.04.23.21255846

Ferreras-Antolin L, Bielicki J, Warris A, Sharland M, Hsia Y, & GARPEC Network. (2021). Global Divergence of Antifungal Prescribing Patterns: Data from the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children Surveys. Pediatric Infectious Disease Journal, 40(4), 327–332. https://doi.org/10.1097/INF.0000000000002983

Gastine S, Hsia Y, Clements M, Barker CIS, Bielicki J, Hartmann C, Sharland M, & Standing JF. (2021). Variation in Target Attainment of Beta-Lactam Antibiotic Dosing Between International Pediatric Formularies. Clinical Pharmacology and Therapeutics, 109(4), 958–970. https://doi.org/10.1002/cpt.2180

Kohns Vasconcelos M, Epalza C, Renk H, Tagarro A, & Bielicki JA. (2021). Harmonisation preserves research resources (Patent No. 4). 21(4), Article 4. https://doi.org/10.1016/S1473-3099(20)30585-5

Kohns Vasconcelos M, Renk H, Popielska J, Nyirenda Nyang’wa M, Burokiene S, Gkentzi D, Gowin E, Donà D, Villanueva-Medina S, Riordan A, Hufnagel M, Eisen S, Da Dalt L, Giaquinto C, & Bielicki JA. (2021). SARS-CoV-2 testing and infection control strategies in European paediatric emergency departments during the first wave of the pandemic. European Journal of Pediatrics, 180(4), 1299–1305. https://doi.org/10.1007/s00431-020-03843-w

Leuzinger K, Gosert R, Søgaard KK, Naegele K, Bielicki J, Roloff T, Bingisser R, Nickel CH, Khanna N, Sutter ST, Widmer AF, Rentsch K, Pargger H, Siegemund M, Stolz D, Tamm M, Bassetti S, Osthoff M, Battegay M, et al. (2021). Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures. Journal of Medical Virology, 93(4), 2374–2384. https://doi.org/10.1002/jmv.26731

Buettcher M, Trueck J, Niederer-Loher A, Heininger U, Agyeman P, Asner S, Berger C, Bielicki J, Kahlert C, Kottanattu L, Meyer Sauteur PM, Paioni P, Posfay-Barbe K, Relly C, Ritz N, Zimmermann P, Zucol F, Gobet R, Shavit S, et al. (2021). Swiss consensus recommendations on urinary tract infections in children. European Journal of Pediatrics, 180(3), 663–674. https://doi.org/10.1007/s00431-020-03714-4

Buettcher M, Trueck J, Niederer-Loher A, Heininger U, Agyeman P, Asner S, Berger C, Bielicki J, Kahlert C, Kottanattu L, Meyer Sauteur PM, Paioni P, Posfay-Barbe K, Relly C, Ritz N, Zimmermann P, Zucol F, Gobet R, Shavit S, et al. (2021). Correction to: Swiss consensus recommendations on urinary tract infections in children. (Patent No. 3). 180(3), Article 3. https://doi.org/10.1007/s00431-020-03820-3

Glinz D, Mc Cord KA, Moffa G, Aghlmandi S, Saccilotto R, Zeller A, Widmer AF, Bielicki J, Kronenberg A, & Bucher HC. (2021). Antibiotic prescription monitoring and feedback in primary care in Switzerland: Design and rationale of a nationwide pragmatic randomized controlled trial. Contemporary Clinical Trials Communications, 21, 100712. https://doi.org/10.1016/j.conctc.2021.100712

Verberk JDM, Anthierens SA, Tonkin-Crine S, Goossens H, Kinsman J, de Hoog MLA, Bielicki JA, Bruijning-Verhagen PCJL, & Gobat NH. (2021). Experiences and needs of persons living with a household member infected with SARS-CoV-2: A mixed method study. PLoS ONE, 16(3 March 2021), e0249391. https://doi.org/10.1371/journal.pone.0249391

Leuzinger K, Roloff T, Gosert R, Sogaard K, Naegele K, Rentsch K, Bingisser R, Nickel CH, Pargger H, Bassetti S, Bielicki J, Khanna N, Tschudin Sutter S, Widmer A, Hinic V, Battegay M, Egli A, & Hirsch HH. (2021). Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. The Journal of Infectious Diseases, 223(4), 734–735. https://doi.org/10.1093/infdis/jiaa667

Cook A, Hsia Y, Russell N, Sharland M, Cheung K, Grimwood K, Cross J, Cotrim da Cunha D, Magalhães GR, Renk H, Hindocha A, McMaster P, Okomo U, Darboe S, Alvarez-Uria G, Jinka DR, Murki S, Kandraju H, Dharmapalan D, et al. (2021). Association of Empiric Antibiotic Regimen Discordance with 30-Day Mortality in Neonatal and Pediatric Bloodstream Infection-A Global Retrospective Cohort Study. Pediatric Infectious Disease Journal, 40(2), 137–143. https://doi.org/10.1097/INF.0000000000002910

Mari, A., Roloff, T., Stange, M., Søgaard, K. K., Asllanaj, E., Tauriello, G., Alexander, L. T., Schweitzer, M., Leuzinger, K., Gensch, A., Martinez, A., Bielicki, J., Pargger, H., Siegemund, M., Nickel, C. H., Bingisser, R., Osthoff, M., Bassetti, S., Sendi, P., et al. (2021, January 4). Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2020.12.28.20248663

Barratt S, Bielicki JA, Dunn D, Faust SN, Finn A, Harper L, Jackson P, Lyttle MD, Powell CV, Rogers L, Roland D, Stöhr W, Sturgeon K, Vitale E, Wan M, Gibb DM, & Sharland M. (2021). Amoxicillin duration and dose for communityacquired pneumonia in children: The cap-it factorial non-inferiority RCT. Health Technology Assessment, 25(60), 1–72. https://doi.org/10.3310/HTA25600

Bortone B, Jackson C, Hsia Y, Bielicki J, Magrini N, & Sharland M. (2021). High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries. PLoS ONE, 16(1 January), e0241899. https://doi.org/10.1371/journal.pone.0241899

Kohns Vasconcelos, M., Meyer Sauteur, P. M., Keitel, K., Santoro, R., Heininger, U., van den Anker, J., & Bielicki, J. A. (2021). Strikingly decreased community-acquired pneumonia admissions in children despite open schools and day-care facilities in Switzerland. The Pediatric Infectious Disease Journal, 40(4), e171–e172. https://doi.org/10.1097/inf.0000000000003026

Mack, I., Sharland, M., Brussee, J. M., Rehm, S., Rentsch, K., & Bielicki, J. (2021). Insufficient stability of clavulanic acid in widely used child-appropriate formulations. Antibiotics (Basel), 10(2), 225. https://doi.org/10.3390/antibiotics10020225

Mari, Alfredo, Roloff, Tim, Stange, Madlen, Søgaard, Kirstine K., Asllanaj, Erblin, Tauriello, Gerardo, Alexander, Leila Tamara, Schweitzer, Michael, Leuzinger, Karoline, Gensch, Alexander, Martinez, Aurélien E., Bielicki, Julia, Pargger, Hans, Siegemund, Martin, Nickel, Christian H., Bingisser, Roland, Osthoff, Michael, Bassetti, Stefano, Sendi, Parham, et al. (2021). Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance. Microorganisms, 9(5), 1094. https://doi.org/10.3390/microorganisms9051094

Stange, Madlen, Mari, Alfredo, Roloff, Tim, Seth-Smith, Helena M. B., Schweitzer, Michael, Brunner, Myrta, Leuzinger, Karoline, Sogaard, Kirstine K., Gensch, Alexander, Tschudin-Sutter, Sarah, Fuchs, Simon, Bielicki, Julia, Pargger, Hans, Siegemund, Martin, Nickel, Christian H., Bingisser, Roland, Osthoff, Michael, Bassetti, Stefano, Schneider-Sliwa, Rita, et al. (2021). SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathogens, 17(3), ARTN e1009374. https://doi.org/10.1371/journal.ppat.1009374

van Donge T, Fuchs A., Leroux S., Pfister M, Rodieux F., Atkinson A, Giannoni E., Van Den Anker J., & Bielicki J. (2021). Amoxicillin Dosing Regimens for the Treatment of Neonatal Sepsis: Balancing Efficacy and Neurotoxicity. Neonatology, 117(5), 619–627. https://doi.org/10.1159/000509751

Wagner-Hattler, Leonie, Kiene, Klara, Bielicki, Julia, Pfister, Marc, Puchkov, Maxim, & Huwyler, Jörg. (2021). High Acceptability of an Orally Dispersible Tablet Formulation by Children. Children, 8(3), 194. https://doi.org/10.3390/children8030194

Brüningk, S. C., Klatt, J., Stange, M., Mari, A., Brunner, M., Roloff, T.-C., Seth-Smith, H. M. B., Schweitzer, M., Leuzinger, K., Søgaard, K. K., Torres, D. A., Gensch, A., Schlotterbeck, A.-K., Nickel, C. H., Ritz, N., Heininger, U., Bielicki, J., Rentsch, K., Fuchs, S., et al. (2020, December 17). Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2020.12.15.20248130

Vazouras K, Hsia Y, Folgori L, Bielicki J, Aguadisch E, Bamford A, Brett A, Caseris M, Cerkauskiene R, De Luca M, Iosifidis E, Kopsidas J, Manzanares Á, Planche T, Riordan A, Srovin TP, Valdivielso Martínez AI, Vergadi E, Sharland M, & Basmaci R. (2020). Treatment and Outcomes of Children With Febrile Urinary Tract Infection Due to Extended Spectrum Beta-lactamase-producing Bacteria in Europe: TOO CUTE Study. Pediatric Infectious Disease Journal, 39(12), 1081–1087. https://doi.org/10.1097/INF.0000000000002838

André MC, Pätzug K, Bielicki J, Gualco G, Busi I, & Hammer J. (2020). Can SARS-CoV-2 cause life-threatening bronchiolitis in infants? (Patent No. 11). 55(11), Article 11. https://doi.org/10.1002/ppul.25030

Chin MKY, Hsia Y, Goossens H, Versporten A, Bielicki J, Sharland M, & Donà D. (2020). Evidence of Dose Variability and Dosing Below the FDA and EMA Recommendations for Intravenous Colistin (Polymyxin E) Use in Children and Neonates. Pediatric Infectious Disease Journal, 39(11), 1032–1034. https://doi.org/10.1097/INF.0000000000002847

Sharland E, Long P, Sharland M, Bielicki J, Saxena S, Wong ICK, & Barker C. (2020). Early origins of oral penicillin dosing for children. Archives of Disease in Childhood, 105(11), 1118–1119. https://doi.org/10.1136/archdischild-2018-316531